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THERMAL FLUID MODELS OF A HYDROGEL DELIVERY SYSTEM FOR 
PANCREATIC CANCER TREATMENT 
2016-2017 
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Master of Science in Mechanical Engineering 
 
      Pancreatic cancer is one of the most devastating cancers with low survival 
rates. This disease is difficult to detect due to the pancreas’s location deep within the 
body. Therefore, diagnoses are often made in the later stages, making treatment options 
more limited and difficult. It has been hypothesized that direct injection into the tumor 
would enhance drug effectivenes. Therefore, we examined the use of endoscopic 
ultrasound (EUS) combined with a fine needle injection to deliver a drug-eluding 
thermosensitive hydrogel directly into the tumor. Unfortunately, normal body 
temperatures surrounding the EUS can warm the hydrogel drug combination beyond its 
phase transition temperature before its final destination inside the tumor. A modified 
version of FocalCool’s technology CoolGuide™ catheter, now called the CoolGuide™ 
sheath, will be used to provide temperature control along the injection pathway, ensuring 
that the hydrogel remains below its phase transition temperature LCST.The objective of 
this work is to build and explore thermal fluid models of a temperature controlled device 
using a finite volume conjugate heat transfer approach. Using experimental results for 
validation we intend to demonstrate that the sheath has the ability to control and deliver 
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               1.1.1 Pancreatic cancer overview. Pancreatic cancer is one of the most 
devastating cancers. This disease, in which malignant tumors form in the organ 
responsible for creating digestive enzymes, is currently the fourth leading cause of cancer 
death in the United States and is predicted to become the second by 2020 [1].It has a five 
year relative survival rate of just 4%. An estimated 73% of patients will die in the first 
year of diagnosis[2]. The number of patients with  pancreatic cancer will increase more 
than 2-fold and the number of death will increase 2.4-fold by the year 2030[3]. The most 
common risk factors for developing pancreatic cancer are family history of the disease, 
age, smoking, obesity and long-standing diabetes. 
               1.1.2 Stages of pancreatic cancer. Pancreatic cancer has a very low survival rate. 
Of all adults with pancreatic cancer,19 % live for 1 year after they are diagnosed, only 
about 4% has a five year survival rate[4]. The outcome of pancreatic cancer depends on 
how advanced the cancer is when it is diagnosed. In other words, it depends on the stage of 
the pancreatic cancer. There are 4 stages of pancreatic cancer [5]. 
 Stage1: In this stage, the cancer is completely inside the pancreas and has not spread to   




             -Stage 1A: The cancer is completely inside the pancreas with a tumor size smaller 
than 2cm. No cancer in the lymph nodes or other areas of the body. 
              -Stage 1B: Here there is no cancer in the nodes or other areas but the tumor size 
is bigger than 2cm. 
             Stage 2: This stage also has two parts: 
            -Stage 2A: The cancer has started to grow into surrounding tissues but no cancer is 
in the  nearby blood vessels or lymph nodes. 
             - Stage 2B: The cancer can be any size and may have grown into the tissues 







Figure 1. Stage 2B of pancreatic cancer. Here the tumor has grown into the surrounding 
tissues and the nearby lymph nodes.[6] 
 
 Stage 3: In this stage the cancer is designated as locally advanced pancreatic cancer 
(LAPC), it is growing outside the pancreas, into the nearby large blood vessels. However, 
it has not spread to other areas of the body.  
Stage 4: The cancer has spread to other areas of the body such as the liver or lungs. It is 
also called metastatic cancer. 
                 1.1.3 Treatment of pancreatic cancer. The location of the pancreas deep inside 
the body makes the tumor hard to find and diagnose in its early stages. Patients usually 




             Treatment of pancreatic cancer  depends on the stage of the tumor. Chemotherapy 
is a  common option for treating locally advanced pancreatic cancer (LAPC). Most 
patients are treated with Gemcitabine. Surgery is often necessary for tumor removal, 
however, surgical tissue removal is only a viable option for about 20% of patients. 
                1.1.4 Endoscopic Ultrasound. Accurately diagnosing pancreatic cancer 
patients is very important to select the optimal treatment for their disease. One approach 
that holds promise is the use of endoscopic ultrasound (EUS) combined with a fine 
needle injection. The EUS simultaneously provides primary diagnostic and staging 
information[8]. Early in its development, the EUS demonstrated its superiority over other 
endoscopic imaging modalities[9]. Over the last 20 years, EUS has gone from an imaging 
modality to an interventional procedure. The use of an endoscopic ultrasound (EUS) 
combined with a fine needle injection was examined to deliver drugs directly into the 
tumor. Some of the work with EUS-guided FNI included botulinum toxin injection for 
patients with pancreatic pain from pancreatic malignancy[8]. These applications 
demonstrated the feasibility and safety of EUS-guided FNI. This technique was extended 
to the application of delivering antitumor agents. 
          1.1.5 EUS-Guided antitumor injection. An EUS-guided injection of allogenic 
mixed lymphocyte culture (Cytoimplant) in patients with LAPC was reported in 2000[8]. 
In this study, doses of cytoimplant cells were delivered slowly and steadily into pancreatic 
tumor for eight patients by a single EUS-guided FNI. Patients received different number 




and safe. A final evaluation was made at 24 months to follow up with the tumor regression. 
Two patients had a partial response and one patient had a minor response. The overall 
median survival was 13.2 months. 
A second phase I/II trial involving EUS-guided injection of ONYX-015, were performed 
in 2003 by Hecht et al [10],this study included 21 patients over an 8-week period. Patients 
received up to 10 injections consisting of 1 mL of virus depending on the tumor size. In a 
second testing, a combination therapy was investigated by adding Prophylactic antibiotics 
to the initial drug. 
               The first study without the combination therapy showed that no patients had a 
tumor response at day 35. After combination, two patients had partial regressions and two 
had minor regressions, six had stable disease and the remaining 11 patients had progressive 
disease. The overall median survival was 7.5 months. 
               Most recently (2005), a multicenter phase I clinical trial of a novel gene transfer 
therapy (TNFerade) was completed against unresectable, LAPC. The drug was delivered 
by an EUS-guided FNI. The treatment involved Thirty-seven Patients who received 
intratumoral injections of TNFerade during 5 weeks. 73% of patients in the EUS group had 
tumor stabilization, with 13 % having a >50% reduction in tumor size at 3 months. 
However the Localized intratumoral (IT) injection of a liquid drug is limited by lesion 
characteristics causing unsafe drug leakage into surrounding tissues (Fig.2). 




direct liquid drug injection since they can undergo a phase transition presenting a drug 









Figure 2. Up-close section to pancreas lesion [37]. Effectively treating 
 LAPC is challenging because lesions are hypovascular, have a high interstitial 
 pressure, and have a dense extracellular matrix. The lesion characteristics limit  
systemic drug effectiveness. 
 
                1.1.6 Hydrogels overview. For over fifty years hydrogels have been used in 
numerous biomedical applications such as manufacturing contact lenses, hygiene 
products, tissue engineering scaffolds, drug delivery systems and wound dressings. The 
main advantage of these hydrogels is that they have potential biomedical uses; they are 






other applications and they are currently present in other advanced applications, such as 
drug delivery systems [11]. 
              1.1.7 Hydrogels as a drug delivery system. The thermosensitive hydrogels are 
polymers that can undergo a transition to a semisolid depot into the tumor tissue under 
variation of temperature [12]. A hydrogel consists of a network of polymer chains that are 
either covalently bounded, ionically bounded or linked through intermolecular force (Fig. 
3). They are swollen networks pocessing a hydrophilic character allowing them to swell 
and form gels in contact with water and under certain stimuli[13] such as temperature, 
solvent quality, pH, elastic field, etc [14]. 
 
 
Figure 3. Schematic of hydrogel structure with hydrophilic polymer chains 
connectedthrough crosslink points or crosslinking polymers [15]. Mc designates the 
number average molecular weight between two adjacent crosslinks and ξ represents the 





            For biomedical applications such as drug delivery system, thermosensitive 
hydrogels are widely used as the temperature at which they form gels are adjustable[14]. 
They may be injected in liquid form, stiffening inside the body due to the change in 
temperature[13].   
             When a thermosensitive hydrogel reacts with water in the right temperature, the 
hydrophobic parts of the polymer will attract each other and create micelles which are are 
lipid molecules that arrange themselves in a spherical form in aqueous solutions. The 
micelles will aggregate and bind water, therefore forming a gel. The formation of the gel 
depends on the structure of the molecules and its mass. A typical thermosensitive hydrogel 
is a poloxamer (PEO-PPO-PEO), it consists of 2 monomers, PEO (poly(ethylene oxide)) 
and PPO (poly(phenylene oxide)). PEO is a hydrophilic monomer, whereas PPO is a 
hydrophobic monomer [16]. 
 
 
Figure 4. Schematic illustration of the micellar phases formed by the Pluronics 
(hydrogel) with increasing temperature [17]. From left to right, the temperature is 
increasing. The formation of a micelle is a response to the amphipathic nature of fatty 
acids, meaning that they contain both hydrophilic regions (polar head groups) as well      





            One of the common hydrogels used is the Pluronic F127. This hydrogel contains 
molecules that can self-assemble into micelles in aqueous solutions above critical micelle 
concentrations. The critical micelle concentration decreases with increasing temperature. 
As temperature increases, micelles appear and lead to gel form, thus F127 has the ability 
to undergo sol-gel phase transition by the change of environmental temperature. Pluronic 
F-127 presents an attractive drug encapsulating device since it has unique thermoreversible 
characteristics such as the dynamic viscosity. Fig. 5 shows the complex viscosity variation 
of the Pluronic F127 as a function of temperature as well as the storage G' and the loss 
Modulus G". These tests were conducted at a constant shear rate. The complex viscosity, 
*  is characterized by the frequency-dependent viscosity function determined during forced 






Figure 5. Mechanical behavior of hydrogel F127 investigating storage, loss          
modulus, and complex viscosity as a function of the temperature. 
 
               Encapsulating a common can drug like Gemcitabine in a thermally reversible 
hydrogel allows the drug to be injected as a liquid, transitioning into a gel inside the tumor 
at body temperature (Fig.6).  As a result, a hydrogel-drug combination creates a drug 






Figure 6. Hydrogel F-127 Nanocomposite Chemical behavior. Inside the F127              
sol-gel are free Gemcitabine and nanoparticles which are made of free Gemcitabine     
and Gemcitabine conjugated with PLA.(Jennifer Mitchell, private communication,            
April 20th, 2017) 
 
            An injectable thermosensitive hydrogel was developed by Chen et al [13]. This 
delivery system has the ability to undergo sol-gel phase transition under body temperature 
conditions. In their study, they introduced the Hexamethylene diisocyanate (HDI) into 
Pluronic-F127 as a chain extender to improve its mechanical stability. Results showed that 
the HDI-PF127/HA nanocomposite hydrogel can be solidified at temperatures near the 
body temperature condition, 37C .The study showed that the release of anticancer drug 
DOX from HDI-PF127/HA composite hydrogel was a zero order profile and sustained drug 







Figure 7. Example of drug release from a hydrogel showing the degradation                  
and diffusion of the hydrogel. The circular red parts present the drug being diffused      
from the swollen hydrogel represented by the black lines. 
 
 
             1.1.8 Integrated use of hydrogels with EUS.The use of endoscopic ultrasound 
(EUS) combined with a fine needle injection to deliver a drug-eluding hydrogel directly 
into the tumor has been examined. Fig. 8 shows a picture of an endoscopic ultrasound and 




      
Figure 8. Schematic of an endoscopic ultrasound and fine needle injection               
(EUS-FNI), which could be a viable option for a minimally invasive drug delivery     
system to the pancreas[19]. 
 
 
             Matthes et al [20] invented a new technique to provide a minimally invasive local 
treatment option for unresectable pancreatic tumors. In this study Oncogel 
(ReGel/paclitaxel) was examinated. The ReGel, is a thermosensitive biodegradable 
triblock copolymer combination of poly(lactide-co-glycolide)-polyethylene glycol-
poly(lactide-co-glycolide)[20]. The Oncogel was injected under EUS-guidance, with a 22- 
gauge needle into the tail of pancreas. This study included Eight Yorkshire breed pigs. 
Experiments showed that the EUS-guided injection of OncoGel provided a high and sustain 
localized concentration of paclitaxel into the pig pancreas (Fig.9). The procedure has 
shown its ability to perform safely and without complications for the animals however, 




pressure needed to push the gel down the FNI shaft, caused the gel to leak around fittings 
which were not designed for high pressure. This was a result of the sol-to-gel phase 
transition that occurred within the FNI needle. The hydrogel-drug combination was 
warmed to a temperature that exceeded the lower critical solution temperature (LCST). 
 
 




              1.1.9 Hydrogel delivery challenges. Unfortunately, normal body temperatures 
surrounding the EUS can warm the hydrogel drug combination beyond its phase 
transition temperature or lower critical solution temperature (LCST) before its final 
destination inside the tumor.  This transition leads sharp viscosity increases and injection 
pathway plugging, requiring unrealistic delivery pressures [20]. To address this problem, 




CoolGuide™ sheath, will be used to provide temperature control along the needle 
injection pathway, ensuring that the hydrogel remains below its LCST through most of its 
pathway.  The CoolGuide™ sheath is made of Pebax® and includes three lumens 
(Fig.10), a central circular lumen for hydrogel flow as well as wing-shaped lumens for 
the coolant. The coolant pathway has a slot at the distal end to allow the closed-loop 
circulation of coolant. 
 
 
Figure 10. Schematic of the CoolGuide sheath. This figure shows: a central lumen         
for hydrogel flow (1), an inlet coolant flow (2), an outlet coolant lumen (3) which       




             In pre-clinical testing CoolGuide™ technology has already shown that it has the 
potential to save heart tissue using localized rapid therapeutic hypothermia after heart 
attacks[21].  Recently the original CoolGuide™ was tested inside a mock Endoscopic 




temperature is maintained below the LCST.  Figure 11 shows the mock Endoscopic 





1.2.  Problem Statement 
 
1.2. Problem Statement 
To our knowledge there are no published models that predict delivery temperature and 
pressure using thermosensitive hydrogels. The goal of this thesis work is to develop a 
thermal fluid model for hydrogel delivery system using the CoolGuide™  technology 
inside the EUS. Using experimental results for validation, we intend to demonstrate that 
the CoolGuide™ technology has the capability to successfully deliver drug-laden hydrogel 
Figure 11. Schematic of the mock EUS system (gray) and CoolGuide™ (blue).                             
The mock EUS was created with a braided metal tube partially surrounded with a helical              
tube heat exchanger to maintain body-temperature boundary conditions. A cooling console    






into pancreatic tumors.  In addition, we intend to enhance the original CoolGuide™ design 
so that it improves temperature control performance for this new application.  Research 
and development work will include three thermal fluid models:   
Model 1: A finite volume conjugate heat transfer model of the original design of the 
CoolGuide™ catheter that is validated with pre-existing experimental work inside a mock 
cardiovascular system. 
Model 2: A finite volume conjugate heat transfer model of the original CoolGuide™  used 
without a standard fine needle injection (FNI) needle and validated with our mock EUS 
test loop. 
Model 3: A finite volume conjugate heat transfer model of the original CoolGuide™  used 
with a standard fine needle injection (FNI) needle and validated with our mock EUS test 
loop.  
Model 4: A finite volume conjugate heat transfer model that refines the original CoolGuide 
sheath in terms of improved temperature control capability. 
 




Figure 12. 3D model of the distal end of an EUS system showing the CoolGuide™ 
cooling sheath and the fine needle injection needle (FNI).  In a clinical setting the        









1.3. Thesis Organization  
           The rest of the thesis is structured as follows. The mathematical equations are 
outlined in Chapter 2 to better define flow in straight tubes with constant and variable 
material properties. More focus will be given to non-Newtonian fluids. These details are 
important to develop the thermal fluid models.  
          In Chapter 3, we develop CFD models to investigate the cooling performances of a 
temperature controlled sheath (CoolGuide). We first studied the CoolGuide catheter inside 
a mock cardiovascular system, then a modified version of the catheter now called 
CoolGuide sheath was used to demonstrate its ability to deliver thermosensitive hydrogels 
under body temperature conditions. These models are validated with experimental work. 
Chapter 4 gives an insight about the different CoolGuide sheath optimized models to 
enhance its performances for the pancreatic cancer application. Features such as, hydrogel 
circulation lumen and coolant lumens were optimized for better cooling. Therefore, lower 
delivery temperatures were achieved. 
           Finally, a restatement of the results and Future work recommended are presented 









 Physics Foundation 
           This chapter will discuss the background needed to understand how the 
computational models are solved. There is a need to describe the governing equations that 
are required for a solution. This includes studying laminar flow in straight tubes with both 
constant and variable properties. This work will set the stage for in-depth fluid models such 
as non-Newtonian fluids and the characteristics of the shear thinning behavior of 
thermosensitive hydrogels. 
2.1. Steady Isothermal Flow in a Straight Tube 
 In this section, we will introduce the basic steps to solve an isothermal flow inside 
a simple pipe with constant material properties. A set of steps are necessary to solve a 
CFD model.  
- Defining the geometry (length, diameter…) 
- Defining the governing equations necessary for the model. 
- Setting the boundary conditions and initial conditions in order to solve the governing 
equations. 
- Setting the material properties. 
- Solving the model with the appropriate CFD approach. 




          2.1.1 Geometry. Fig.13 shows a 3D model of a simple pipe with a diameter D and 
length L. The flow is one directional, will enter the pipe from the inlet and leave from the 
outlet. 
 
Figure 13.  3-D schematic of a straight tube of length L and diameter D. Flow is  
steady and fully developed, meaning the fluid velocity profile is parabolic in the          
tube and does not change over the length of the tube. 
 
          2.1.2 Governing equations. In this study we will consider the motion of fluids and 
we will treat them as continuum. The three primary unknowns that can be obtained by 
solving these equations are: velocity, pressure, and temperature. The flow is assumed to 
be governed by the laminar Navier-Stokes equations, mass conservation and energy 
conservation, which may be written in differential form as: 
          2.1.2.1. Conservation of mass. The conservation of mass equation can be 
established using the Eq. (2.1). 




        2.1.2.2. Conservation of momentum. Equations for the conservation of momentum 
for a fluid are known as the Navier-Stokes equations which are written in three-
dimensional Cartesian coordinates Eq. (2.2): 












































































The equation can also be written in its more general form as shown in Eq. (2.3): 
                                  ρ(
∂v⃗ 
∂t 
 + ?⃗? ·∇ ?⃗? ) = -∇p+  μ 𝛻2 ?⃗?  ,                                                  (2.3) 
 
where ρ is the fluid density (kg/𝑚3), ?⃗?  is the fluid velocity vector (m/s), p is the fluid 
pressure (Pa), μ is the dynamic viscosity (Pa-s).                                                                                                         
            2.1.3 Boundary conditions. To solve the governing Eqs (1), (2) and (3) , boundary 
conditions are required. The isothermal model consists of a primary domain for the fluid 
flowing through the tube. (Fig.14) provides a description of these boundary conditions for 





Figure 14.  3-D model of the simple pipe showing the boundary conditions.                 
The inlet boundary condition for the isothermal model is set to a velocity inlet, the       
outlet is set to a zero pressure outlet. The wall has a no-slip condition which         
constrains the velocity to zero along it. 
 
 
           2.1.4 Material properties. For any CFD model, material properties are needed. 
They define the properties of parts which impact the physics of a simulation. For an 
isothermal model, the material properties necessary are the density of the fluid and the 
dynamic viscosity.  
           2.1.5 Model validation. The validation is an indispensable step to build 
confidence in modeling. This step could be achieved with experimental work, published 
work and analytical or empirical solutions. One of the equations for validating a flow 
through a simple pipe is the pressure drop equation. Eq. (2.4) shows the pressure drop 












 ,                                                             (2.4) 
where ρ is the fluid density  (kg/𝑚3), 𝑓𝐷𝑊𝐷 is the friction factor for the developing flow; 
It represents the weighted average of fully developed flow and developing flow [22], L is 
the length of the catheter in (m), D is the diameter of the catheter  (m) and 𝑉𝑎𝑣𝑔 is the 
velocity at the inlet (m/s). 
The average velocity at the inlet of the tube was calculated by setting a constant flow rate 
with a fixed cross-sectional area using Eq.(2.5): 
                                                                   Q=𝑉𝑎𝑣𝑔A ,                                                                  (2.5) 
where 𝑄 is volumetric flow rate (𝑚3/s), 𝐴 the cross-sectional area in (𝑚2), and 𝑉𝑎𝑣𝑔 is the 
inlet velocity in (m/s). 
2.2  Non-Isothermal Flow With Variable Properties in Simple Tubes 
          2.2.1 Geometry. We consider the same pipe of diameter D and length L. The flow is 
one directional, will enter the pipe from the inlet and leave from the outlet. The pipe is 
heated with a constant wall temperature (Ts). 
          2.2.2 Governing equation. The same equations (Eq.2.1 and 2.2) are applied to the 
non-isothermal flow except that there is and additional equation that needs to be 




           2.2.2.1. Conservation of Energy .The energy equation can be written in many 
different ways, but in our case the problem is 3-dimensional, steady state and there is no 
heat generation. The final expression is given by Eq. (2.6): 



























)] ,                    (2.6)                                                                                          
where T is the absolute temperature (K), k is the thermal conductivity (W/m-C), ρ is the 
density and 𝐶𝑝 is the specific heat (J/kg-K)                                       
            2.2.3 Boundary conditions.  Fig.15 shows the boundary conditions applied to the 
heated pipe. The flow will penetrate the pipe with a constant temperature and flow rate. 
The outer wall is exposed to constant temperature Ts. 
 
 
Figure 15. Boundary conditions for the simple pipe model. The inlet boundary      
condition is set to a mass flow inlet condition and temperature. The outlet is set to             
a pressure outlet. The outer wall is exposed to constant temperature and the no slip  






2.2.4 Newtonian fluids. For an incompressible Newtonian fluid in laminar flow, 
the resulting shear stress is equal to the product of the shear rate and the viscosity of the 
fluid medium. The model for Newtonian fluid contained between parallel plates is 




 = 𝜏𝑦𝑥 = μ (- 
𝜕𝑉𝑥
𝜕𝑦
  )= μ γ𝑦𝑥                                       (2.7) 
where, F is the force applied in the x direction, A is the surface area and μ is the dynamic 
viscosity. The Newtonian viscosity is by definition independent of shear rate or shear 
stress and depends only on the material and its temperature and pressure. The plot of 
shear stress against shear rate for a Newtonian fluid is called rheogram and is a straight 
line of slope, 𝜇 and passing through the origin. 
 
 
Figure 16.  Schematic representation of unidirectional shearing flow. This              
represents a thin layer of fluid contained between two parallel plates a distance                   




             2.2.5 Non-Newtonian fluid viscosity behavior. A non-Newtonian fluid has a non-
linear flow curve. The ratio of shear stress and shear rate is not constant at a given 
temperature and pressure but depends on flow conditions such as flow geometry, shear 
rate, etc. 
            Such materials may be grouped into three general classes: (1) time independent or 
generalized Newtonian fluids for which the rate of shear at any point is determined by 
only the value of the shear stress at that point and instant, (2) time-dependent fluids 
which are more complex where the relation between shear stress and shear rate depends 
on the duration of shearing and, (3) visco-elastic fluids exhibiting both characteristics of 




Figure 17. Types of time-independent flow behavior. Three types of fluid behaviors      
are distinguished, (1) Newtonian fluids are characterized by a constant shear rate , (2) 
time dependent fluids where the relation between shear stress and shear rate            
depends  on the duration of shearing, and (3) visco-elastic fluids exhibiting both 




The flow behavior of this class of materials may be described by a constitutive relation of 
the form: 
                                                                     γ𝑦𝑥=f (𝜏𝑦𝑥)                                                   (2.8) 
These fluids may be further subdivided into three types: shear thinning, shear thickening 
and viscoplastic. This thesis will focus on the shear thinning fluid behavior. 
            2.2.5.1. Shear thinning or pseudoplastic fluids. This fluid is characterized by an 
apparent viscosity which decreases with an increase of shear rate. Apparent viscosity 
which is sometimes denoted η, is the shear stress applied to a fluid divided by the shear 
rate. For a Newtonian fluid, the apparent viscosity is constant, and equal to the 
Newtonian viscosity of the fluid, but for non-Newtonian fluids, the apparent 
viscosity depends on the shear rate. Both at very high and very low shear rates, most 
shear thinning polymer solutions exhibit Newtonian behavior.  There are three different 
models that characterize a shear thinning fluid, 1) the power law model, 2) the Carreau-
Yasuda model and, 3) the cross model. They are providing a shear dependent viscosity 
equation. 
          2.2.5.1.1.Power law models . The simplest model to describe a shear-rate 
dependent viscosity behavior is the power law.   The relation between shear stress and 
shear rate is analyzed with different rheological models: Ostwald-de Waele, Herschel-
Bulkley, Bingham, and Casson [24] 




                                                              𝜏 = 𝜏0+ kγ˙
𝑛
                                                  (2.10) 
                                                              𝜏 = 𝜏0+η γ˙
𝑛
                                                  (2.11) 
                                                           𝜏0.5=𝜏0
0.5+ η0.5+γ˙0.5                                       (2.12) 
where, 𝜏 is the shear stress (Pa), γ˙ is the shear rate(1/s), η is the viscosity(Pa-s), 𝜏0 is the 
yield stress(Pa) associated with the critical stress applied for determining the start of 
hydrogel flow, k is the consistency index (Pa-s) related to the hydrogel viscosity, n is the 
flow behavior index (Dimensionless)  
             2.2.5.1.2. The Power Law - WLF viscosity model. This is the model chosen in our 
work.  The simplest model to describe a shear-rate and temperature dependent viscosity 
behavior is the power law relationship that also takes into account an explicit temperature 
adjustment 𝑎𝑇 .[24] 
                                             μ(γ˙)= 𝑎𝑇kγ˙
𝑛−1
                                                     (2.13) 
 
where, k is the consistency factor, n is the power law exponent, and 𝑎𝑇  is the 
temperature shift factor. The value of the power law exponent n determines the class of 
the fluid: 
     n = 1  Newtonian fluid 
     n > 1  Shear-thickening (dilatant) fluid 




The explicit temperature dependency parameter 𝑎𝑇 is approximated by the Arrhenius and 
Williams-Landel-Ferry (WLF) equation[25]. The WLF equation has been used widely to 
describe the temperature dependence of the viscosity and relaxation time in polymeric 
systems [25]. The empirical equation is given by Eq. (2.13): 
                                            Log 𝑎𝑇 = 
−𝐶1(𝑇−𝑇0)
𝐶2+(𝑇−𝑇0)
                                                          (2.13) 
where, 𝑎𝑇 is the temperature shift factor, 𝑇0 is the reference temperature to which the 
curves (viscosity vs (T-To))[25] are generated by shifting the dynamic mechanical test 
data at other temperatures, and 𝐶1and 𝐶2 are material coefficients determined by fitting 
the test data of the shift factor. For many polymers, 𝐶1 and 𝐶2 are estimated to 17.4 and 
51.6 respectively [26]. 
              2.2.5.1.3.The Carreau viscosity model. Although this model was not used in our 
research, it is used to account for the significant deviations from the power law model at 
very high and very low shear rates[23]. It is expressed by Eq (2.14): 
                                 
 μ−μ∞
μ−μ0
 = ( (1 + (𝜆γ˙)2)
𝑛−1
2                                  (2.14) 
where,  μ is the apparent viscosity(Pa-s), μ∞ is the dynamic viscosity at infinite shear 
rate(Pa-s), μ0  is the dynamic viscosity at zero shear rate(Pa-s) , γ˙  is the shear rate(𝑠
−1), 






              2.2.5.1.4. The Cross viscosity model. Once again, even though this model was not 
used, it is appropriate to use the Ellis model when the derivations from the power-law 
model are significant only at low shear rates. 
                                  μ= μ∞+ 
 μ−μ∞
(1+(kγ˙))𝑛
                                  (2.15) 
where, μ is the apparent viscosity(Pa-s), μ∞ is the dynamic viscosity at infinite shear 
rate(Pa-s), μ0  is the dynamic viscosity at zero shear rate (Pa-s), γ˙ is the shear rate (𝑠
−1), 
k is the consistency factor, and n is the power law exponent. 
             2.2.6 Other material properties. Other temperature dependent properties, such as 
cp, rho, and thermal conductivity, can be approximated by using a polynomial function of 
the form: 
                        M =a0+a1T+a2T2+a3T3+a4T4+a5T5+…+anTn   ,                                              (2.17) 
where M is the  material property of the hydrogel and water, T is the temperature of the 
fluid in(C),  ai (i=0,1,2,3,4,5,..n) are coefficients determined by a polynomial of the material 
property.  
2.3.  Finite Volume Method – STAR-CCM+ 
              This section introduces the Finite Volume Method (FVM) for the solution of 
partial differential equations. These methods are widely used due to their robustness and 
computational advantage such us solving complex problems such as turbulent models and 




               2.3.1 Finite volume method. The finite volume method (FVM) is utilized as a 
discretization technique for partial differential equations. The integral conservation law is 
enforced for small control volumes defined by the computational mesh. The objective is to 
obtain linear algebraic equations with the total number of unknown in each equation 
system. Transforms the mathematical model into a system of algebraic equations. This 
means discretizing the governing equations in space and time. The resulting linear 
equations are then solved with an algebraic multigrid solver. 
             2.3.2 Geometry and mesh. Consider a domain subdivided into a finite number of 
control volumes. The pattern created by the lines setting the boundaries of the control 
volumes is called the computational grid or mesh. Fig. 18 shows an example of a control 
volume. A node is referred to P, and the neighbors are designated E for east, W for west, 
N for north, and S for south. 
 
Figure 18.  Example of a typical control volume[27]. The nodes are                           




                2.3.3 Mathematics. Integral form of conservation law: The partial differential 
equation is valid at all points in the domain. The domain is subdivided into small number 
of control volumes dv and the conservative form is derived for a finite volume dv bounded 
by a surface ds. The non-linear governing equations are solved iteratively one after the 
other for the solution variables such as u, v, w and p. 
             When the appropriate constitutive relations are introduced into the conservation 
equations a closed set of equations is obtained. All conservation equations can be written 
in terms of a generic transport equation. By integrating the generic transport equation 
over a control volume dV and applying Gauss's divergence theorem. 
             2.3.4 Tool to apply the FVM. All the models were developed based on the finite 
volume method (FVM) using the commercial software STAR-CCM+ (11.02). STAR-
CCM+ uses discretization methods to convert the continuous system of equations to a set 











Thermal Fluid Models 
            This chapter will discuss the computational methods used to solve the different 
thermal fluid models outlined. First a breakdown of the model will be presented to 
emphasize the difference between the different thermal fluid models then, a description of 
each model will be conducted separately with the different steps to solve the CFD model. 
3.1 Modeling Objectives 
          The goal of this thesis work is to design a hydrogel delivery system. We intend to 
develop thermal fluid models of the CoolGuide™ technology inside the EUS system. 
Using experimental results for validation, we intend to demonstrate that the CoolGuide™ 
catheter has the capability to control hydrogel temperature along the injection pathway.  
          The thermal fluid model will be created using a finite volume conjugate heat transfer 
approach.Using experimental results for validation we demonstrate that the sheath has the 
ability to reduce blood analog delivered temperatures, 2) control distilled water 
temperatures, and 3) help deliver drug encapsulated hydrogel into pancreatic lesions below 
its LCST. This section provides a description of the models developed in this study. 
Model 1 studied a CoolGuide catheter that was used to cool blood analog while 
circulating through the aorta. 
Model 1 was used as a validation process of the CoolGuide catheter. 




Model 3 studied a thermal fluid model of the hydrogel delivery system using the EUS 
and the FNI-Needle. The geometry included the CoolGuide sheath, the FNI needle and 
the EUS system. 
Model 4 is an optimized model of the CoolGuide sheath that will be shared in Chapter 4. 
3.2.  Models  
            3.2.1 CoolGuide design overview. Previous use with a mock cardiovascular 
system :Heart disease continues to be the leading cause of death in the United States [28]. 
One of the common heart disease is a heart attack. A heart attack occurs when the blood 
flow to a part of the heart is blocked by a blood clot. If this clot cuts off the blood flow 
below the ischemic threshold, the part of the heart muscle supplied by that artery begins 
to die. Heart specific cooling devices may provide local, rapid cooling that might save 
tissue at risk. A cooling catheter CoolGuide™ (Fig.19) was designed and tested by 
FocalCool, LLC to provide access to the heart and provide protection by rapidly cooling 






Figure 19. CoolGuide™ catheter design. The catheter consists of an inlet coolant                   
lumen (1), an outlet coolant lumen (2), central lumen for blood analog flow (3)             
and a slot (4) which allows for coolant turnaround.[21]. 
 
 
Figure 20. Schematic of the heart showing the CoolGuide™ distal tip inserted into                




           3.2.1.1. New use with EUS and hydrogel delivery. A modified version of the 
CoolGuide™  catheter now called CoolGuide™  sheath will be used in conjunction with 
an FNI-Needle and an Endoscopic ultrasound system to help deliver thermosensitive 
hydrogels into pancreatic lesions. Fig.21 shows a Solidworks rendered model of the EUS 




Figure 21. Solidworks rendered model of the EUS system. This includes the             
endoscope, the FNI-Needle and the CoolGuide™ sheath. 
 
 
3.2.2 CoolGuide validation with the mock cardiovascular system.  
            3.2.2.1 Materials and methods. To explore the CoolGuide™ catheter cooling 
performances we (1) developed a mock cardiovascular system that simulates the conditions 
inside the carotid artery. (2) Developed a thermal fluid models using a finite volume 




             3.2.2.1.1 Experimental setup. Fig.22 shows the mock cardivascular system. This 
system was built and tested by Merrill et al[21].  The CoolGuide™ catheter was placed 
inside a glass aorta. The system included two circuits. A circuit for blood analog (38% 
glycerol and 62% disttilled water) which was pumped at a flow rate of 3.5 L/min through 
the glass aorta (1),a circuit for the same flowing fluid but pumped through the internal 
Lumen of the CoolGuide™ catheter at differnet flow rates (2), and (3) a path for the coolant 




Figure 22.  Schematic of the mock cardiovascular system. The CoolGuide™             
catheter is placed inside a glass aorta. This device is labeled catheter. The two                   
dashed lines present the inlet and outlet for the coolant flow.[23].    
 
           3.2.2.1.2 Mathematical statement. Fig.23 shows a 3D model of the CoolGuide™ 




shaped lumen for the coolant. The coolant side turns at the end to allow for outflow. An 
outer braid is added to the CoolGuide™ catheter to add stiffness to the model [21]. Based 
on previous experimental work the length and diameter of the different lumens were 
imposed to achieve the goal of heart cooling[21].(Table 1).  
 
     
Figure 23. 3D model of the CoolGuide™ catheter. This figure shows: a central         
lumen for blood analog flow (1), an inlet coolant lumen (2), an outlet coolant lumen      
(3) which carries the coolant from distal tip to the coolant exit and a slot (4) which     
allows for coolant turnaround.         
 
 
Table 1  
Dimensions of the CoolGuide™ catheter 
Geometry Dimension(cm) 
CoolGuide catheter Length 110.0 
CoolGuide catheter inside the aorta 85.0 
CoolGuide catheter Outer diameter  0.267 
CoolGuide catheter Inner diameter 0.157 






a. Governing equations 
In this study we will consider the motion of fluids and we will treat them as continuum. 
The three primary unknowns that can be obtained by solving these equations are: 
velocity, pressure, and temperature. The equations governing the blood analog flow are 
the mass conservation, the laminar Navier-Stokes, and energy conservation equations 
b. Boundary conditions 
           Apart from the geometry, it was necessary to describe the boundary conditions in 
order to be able to solve the governing equations. The numerical analysis is a direct 
comparison to experimental results. Therefore, the boundary conditions were fixed in a 
manner suitable to reproduce the experimental conditions. 
           The model consists of two primary domains, the fluid domain for blood analog 
flow, and distilled water flow as well as a solid domain for the catheter (Teflon core + 
Braid). The body core temperature remains constant due to the blood perfusion (38.4C). 
Since the blood aorta flow is able to transfer heat to the catheter wall by convection, a 
convective boundary condition was applied to that wall. A value of 286.8 W/m2-k was 
chosen based on Eq. (3.19): 
 
                                                Nu = 
h × (Di− Do)
k  
  ,                                                  (3.19) 




 analog (W/m-K),  and 𝐷𝑖 is the aorta average inner diameter (m) and 𝐷𝑜 is the catheter 
outer diameter (m).  Nu, is the Nusselt number of a concentric annulus and equal to 10.44 
assuming concentric annulus[22]. 
            For all simulations, the coolant flow rate and temperature, the catheter thermal 
and flow wall boundary condition and the blood analog inlet temperature were kept 
constant, however the blood analog flow rates were varied from 18.3 ml/min to 76.7 
ml/min to explore its impact on the catheter performances. Fig.24 depicts the boundary 
conditions used for the catheter model. Variable mass flow rates were chosen for inlets to 
keep consistent with previous experimental work[21]. 
•  0.85 m of the CoolGuide™ is inside of the aorta blood and exposed to blood side 
convection (haorta). 
• All CoolGuide™ walls apply the no slip condition, which constrains the velocity to 
zero along it. 
• The blood analog is pumped at variable mass flow rates and constant temperature. 
• The coolant is pumped at constant mass flow rate and temperature. 
• The outlet boundary condition is set to a zero pressure outlet for both the blood analog 







Figure 24.  Boundary conditions for the CoolGuide™ model at the inlet. The inlet 
boundary conditions for both coolant and blood analog are set to a mass flow inlet 
condition. The outlets for the blood and coolant sides were set as pressure outlets.            
The wall, has a no-slip condition that will constrain the velocity to zero along it. 
 
 
Table 2  
Boundary conditions assigned for the different domains of the CoolGuide™ catheter. 
Boundary Boundary Condition Value 
Blood analog inlet [1]  Mass Flow Rate 
18.3 ml/min –76. 
7ml/min 
Blood analog inlet 
temperature [1] 
Temperature 38.4° C 
Blood analog exit [outpout] Pressure Outlet 0 [Pa] 
Coolant inlet [2] Mass Flow Rate 45 ml/min 
Coolant inlet Temperature 
[2] 
Temperature 4° C 
Coolant exit [3] Pressure Outlet 0 [Pa] 
Catheter outer wall (Inside 
aorta) [4]  







c. Material properties 
The material properties that were assigned to both fluid and solid domains are listed in 
Table3. This includes, the blood analog, distilled water, the CoolGuide™ catheter and the 
outer braiding. The blood analog is a 38% by volume Glycerol (Appendix A).The braiding 
is a mixture of stainless steel and Pebax and its thermal properties were determined based 
on the Maxwell derivation for thermal conductivity of composites [29] (See Appendix B).  
 
Table 3  












Distilled water 999.6 0.001236 4186 0.59 






2160 - 1125 0.25 
Braid(Pebax+stainless 
steel composite) 
2500 - 910 0.34 
 
d. Solution Strategy 
A Xi MTower™ 2P64 computer with 3.7 GHz speed, 32GB RAM and 8 cores processor 




STAR-CCM+ version 11.04 based on the finite volume method. The numerical 
computation was considered to be converged when the residuals of all variables were less 
than 1×10-4. More modeling details are seen in Table 4.              
Table 4  






e. Under relaxation factors 
           The under relaxation factors are set by default to 0.9 and 0.99 for fluid and solid 
solvers respectively. If the convergence behavior is acceptable, the under relaxation factors 
for both solid and fluid might be increased to help with convergence speed. In our case, 
were increased to 0.99 and 0.999 for the fluid and solid energy solvers respectively so that 
we increase the convergence rate. The solver solves the equations related to mass, 
momentum and energy. For each case, the values of the variables that the solver is trying 
to solve get closer after each iteration until convergence. Making the under relaxation  
Parameters Value 
Time stepping Steady state  
Tolerance 0.15 
Solver  Segregated flow/Segregated fluid 
temperature 
Flow  Laminar flow 




factor closer to 1, will make the solution more stable like shown in eq. (3.20): 
                                           X k+1 = Urf .X cal + (1-Urf).X k  ,                                        (3.20) 
where, X k   is the variable at iteration k, X k+1  is the variable at the iteration k+1 and Urf is 
the under relaxation factor. 
         3.2.2.2 Results. 
         3.2.2.2.1 Isothermal model. To reduce the computational time, isothermal models 
were conducted to determine the pressure drops for the coolant and blood analog sides. In 
each case, instead of modeling the whole catheter, the fluid region was extracted and 
modeled apart. In each case the blood analog and coolant flow rates were varied, and the 
pressure drop was determined. 
 
a. Mesh for the blood analog side 
           A trimmer mesh was used to generate the volume mesh for the blood analog side, 
and additional prism layers were defined along the wall boundary to ensure that the near 
wall effects are adequately resolved as well as generalized cylinders at the wall. 
           A mesh independence study was performed to minimize the discretization error over 
the computational domain. The test was done by solving an isothermal steady flow 
simulation and predicting the blood analog side pressure drop for a variety of mesh sizes. 
The model was considered to be mesh independent when the pressure drop over the entire 









Figure 25. Plot of Pressure Drop versus number of cells for the model. At       
approximately 21 million elements the model becomes mesh independent. 
          
Fig.26 and 27 show the final volume mesh generated for the internal lumen and a close up 






























Figure 26.  Final mesh generated for the internal circular lumen of the CoolGuide™ 
containing approximately 21 million elements. A surface remesher and a Trimmer mesh 
were used in addition to generalized cylinders to form the volume mesh. 
 
 
         
Figure 27.  A close-up section of the mesh showing the trimmer mesher,                              









b. Mesh for the Coolant Side 
          In this case a trimmer mesh was also used, and additional prism layers were defined 
along the wall boundary. The coolant lumens were extracted from the catheter geometry 
and modeled apart. 
The same test was done for mesh convergence for the coolant side. The model was 
considered to be mesh independent when the pressure drop over the entire domain did not 
significantly change with an increase in the number of mesh elements. The final mesh 




Figure 28. Plot of the coolant side pressure drop versus the number of cells.                      





































Fig.29 and 30 show respectively, the final volume mesh generated for the model and a 
close up section of that same mesh. 
 
 
Figure 29. Final mesh generated for the coolant lumens of the CoolGuide™.                 
The coolant lumens were extracted from the catheter, modeled and meshed             




Figure 30. A close-up section of the mesh showing the trimmer mesher and the         
prism layers at the wall. Three prism layers generated at the wall boundary, were      
enough to ensure that the near wall effects are adequately resolved. 
 
c. Model Validation 
 




         Modeling results were verified through comparison with empirical solutions using          
Eq. (3.21). Fluid flow was validated by measuring the blood analog side pressure drop for 
the different mass flow rates. Results from the two different approaches are listed in 
Table 5 and plotted in Fig.31.  







  ,                                                        (3.21) 
 
where ρ is the fluid density in (kg/𝑚3), 𝑓𝐷𝑊𝐷 is the friction factor for the developing flow 
and is different from the friction factor of a fully developed flow [22], L is the length of 
the catheter in (m), D is the diameter of the catheter in (m) and 𝑉𝑎𝑣𝑔 is the velocity at the 
inlet in (m/s). 
The average velocity at the inlet of the tube was calculated by setting a constant flow rate 
with a fixed cross-sectional area using Eq. (3.22): 
                                                                   Q=𝑉𝑎𝑣𝑔A ,                                                                  (3.22) 
 
where 𝑄 is volumetric flow rate(𝑚3/s), 𝐴 the cross-sectional area in (𝑚2), and 𝑉𝑎𝑣𝑔 is the 





Table 5  
Comparison between the empirical and numerical solution of the different pressure drop 
for different flow rates. 
 




The pressure drop between the entrance and the exit of the blood analog lumen were 
determined at different flow rates. These results show that the numerical solution is in good 
agreement with the empirical solution.  
Flow rate (ml/min) Empirical pressure 
drop (kPa) 
Numerical pressure drop 
(kPa) 
10.0 2.974 3.086 
18.3 5.459 5.510 
26.7 7.972 8.120 
35.0 10.456 10.550 
43.3 12.955 12.836 





Figure 31.  Comparison between the numerical and empirical pressure drops for    
different flow rates of the blood analog. The numerical solution matched the               
empirical solution well. 
 
 
c.ii. Pressure drop prediction for the coolant side  
 
Results for the pressure drop for the coolant side were given by the Eq.(3.23): [21] 



















𝑖=1   ] minor losses                        (3.23) 
where, f is the friction factor, L is the length of the coolant pathway (m), Dh is the hydraulic 
diameter of the coolant lumen (m), 𝑉𝑎𝑣𝑔 is the fluid average velocity (m/s)and ki are the 
























Blood analog flowrate (ml/min)




           Results from Star-CCM+ were compared to the empirical solution and experimental 
results (Fig.32). Fig.32 shows that the numerical solution is in good agreement with the 
experimental work. The average error between the numerical solution and experimental 
work was about 10.5%. Some differences in the predicted values could be attributed to 
several factors; (1) the coolant side has a complicated shape so there is nonlinear 
dependence on the hydraulic diameter and, (2) during experimental work the catheter wall 
got deformed during circulation of coolant which was not accounted for in the numerical 
model.  
 
Table 6  
Pressure drop prediction for the coolant side for different mass flow rates 




10.0 172.500 25.01 
20.0 355.806 51.60 
25.0 449.512 65.19 
30.0 544.637 78.99 





Figure 32.  Experimental data compared to the empirical and numerical predictions       
for the CoolGuide™ coolant pressure-flow behavior. The bars present the standard 
deviation for coolant flow and pressure. 
 
             3.2.2.2.2 Non-isothermal model. In this case, we intend to demonstrate the 
catheter’s ability to reduce blood analog delivered temperatures for a range of flow rates. 
The catheter was partially exposed to ambient temperature, the rest of the model was 
inserted inside the aorta blood (Fig.3). The non- isothermal model will include additional 
boundary conditions such as temperatures and heat transfer coefficient (Table 2). 
a. Mesh 
For a conjugate heat transfer problem where there is variation of temperature within a solid 
and fluid, the mesh type is different. To properly solve the model, we generated a 
polyhedral mesh and additional prism layers were activated on the fluid side of the fluid-



























Coolant mass flow rate(ml/min)




continuums. The solid part had no prism layers however, we activated the embedded thin 
mesher to provide more suitable cells inside the solids. Having 3 layers of cells defining 
the solid thickness is important to resolve the temperature gradients in the solid. 
           Before solving the model, a mesh independence study was performed to minimize 
the discretization error over the computational domain. Using the average exit temperature, 
mesh convergence was achieved with a total number of cells of approximately 24 million 
cells as shown in Fig. 33. Fig. 34 and 35 show respectively the final mesh generated and a 




Figure 33. Plot of the blood exit temperature versus number of cells for the         









































Figure 34. Final mesh generated for the Catheter containing approximately 24 million 
elements. A surface remesher was generated as the surface mesh and a polyhedral mesh 




               
Figure 35. A close up section of the mesh showing the polyhedral cells and the           
prism layers at the fluid-solid interface as well as the 3 layers of embedded thin            







          3.2.2.2.2.1.Model validation.  
a. Exit temperature prediction for the blood analog 
An accuracy check was conducted to validate the CoolGuide™ catheter model. Fig.36 
shows the delivered temperatures results compared to published data. The results seen in 
this figure show the effect of the blood analog flow rate on the average exit temperature. 
When the flow rate increases the delivered temperature increases as well. The numerical 
model predicted the delivered temperatures within 2 °C for flow rates lower than 43.3 
ml/min and 1 °C for the rest of the tested flow rates (Table 7). The numerical results 
matched reasonably well with the experimental work.     
 
Table 7  
Exit temperatures determined with CCM+. 














Figure 36. Experimental data compared to EES and Numerical model predictions        
with varying flow rates and given the same inputs. For flow rates higher than 43.3 
ml/min, all computational values are within 2°C of the experimental data. The error     
bars describe to standard deviation for three data sets. 
 
b. CoolGuide™ catheter cooling capacity 
From the predicted temperatures and flow data of the blood analog, the cooling capacity 
was calculated using Eq. (3.24): 
𝑄𝐵=?̇?𝐵 𝐶𝑝,𝐵(Tc –Tdel) ,                                              (3.24) 
where 𝑄𝐵 is the heat capacity of the blood analog (W), ?̇?𝐵 is the mass flow rate of the 
blood analog in kg/s, Tc is the core temperature (°C) ,Tdel is the temperature at the 









































 capacity of the blood analog J/kg-C (Table 3). 
          The blood analog flow rate ranged from 18.3 ml/min to 76.6 ml/min and Fig.37 
shows the corresponding cooling capacity compared to published data[21]. Even though 
the numerical solution was in good agreement with the present data for flow rates higher 
than 51.7 ml/min, the required minimum cooling capacity of 20 W was achieved for all 
flow rates[21].  
          The average error of the cooling capacity between the numerical solution and the 
experimental data was about 7 %. This new finite volume method was more accurate than 
the empirical solution determined with EES which predicted the cooling capacity within 
approximately, 11% from experimental work. This was expected since the heat transfer 






Figure 37. CoolGuide™ cooling capacity comparison between experimental             
work, numerical   solution and EES model. The error bars indicate the sample                
standard deviation for three different testing. 
 
c. Plot of the temperature and dynamic viscosity as a function of the length for a 
flow rate of 60 ml/min 
          Fig. 38 shows the temperature and viscosity profiles of the blood analog as a function 
of the catheter length. The flow rate of 60 ml/min was randomly chosen to explore the 
blood analog behavior at various longitudinal positions from the inlet to the exit (1.1m) 
with 0.1m increment. At every position, the blood analog temperature and viscosity were 
determined based on the surface average method. The surface average of a scalar 
quantity ϕ inside STAR-CCM+ is computed on a surface as: 
 
                                       Surface average= 
1
𝑎
 ∫𝛷𝑑𝑎 = 
∑ 𝛷𝑓 𝐴𝑓𝑓
∑ 𝐴𝑓𝑓































where, 𝛷𝑓 is the face value of the selected scalar and 𝐴𝑓 is the face area. 
When the temperature of the blood analog decreased from 38.4°C to 26.88°C from the inlet 
to the outlet respectively, the dynamic viscosity increased and matched its associated 
temperature at each position along the catheter. The dynamic viscosity of the blood analog 
is clearly dependent on the temperature. 
 
 
Figure 38. Plot of the blood analog temperature and dynamic viscosity as a            
function of the CoolGuide™ catheter length. The blood analog enters at a constant 
temperature (38.4°C), then gets cooled as it exits the catheter. The dynamic           
viscosity however, increases. 
 
 
          Because the model has different boundary conditions (partly exposed to ambient 









































































tip of the catheter, the temperature and viscosity behaviors are not uniform along the 
catheter length. From the inlet to approximately 0.1m, the temperature of the blood analog 
decreases drastically from 38.4 °C to 31.52° C. This drastic change is due to the heat 
exchanged between the blood analog inside the central lumen, the ambient temperature and 
the coolant. In this region, the catheter is still outside the aorta blood so the heat is 
transferred from the blood analog inside the central lumen (38.4 °C) to the coolant (4° C) 
and ambient temperature. Therefore the blood analog will cool down fast. 
         From 0.1 m to 1 m the temperature of the blood analog decreases from 31.52 ° C to 
26.38° C. Here the catheter is exposed to the aorta blood; the central lumen as well as the 
coolant lumens are gaining more heat, this is why the blood analog takes longer time to 
cool down. At 1 m, the temperature rises slightly until it exists the catheter. In fact at that 
position the coolant temperature is not uniform due to the coolant turnaround. Fig.39 shows 
the coolant temperature distribution at the turnaround. The coolant temperature at location 






Figure 39. Temperature distribution close to the blood analog exit. The temperature 
distribution at the turnaround shows 1) Coolant before the turnaround and 2)         
Coolant temperature after the turnaround. 
 
 
d. Temperature distribution along the coolant pathway  
          Fig. 40 and 41 show a plot of the coolant temperature as a function of the coolant 
pathway. The blood flow rate was kept the same as earlier in the study (60 ml/min) with a 
coolant flow rate of 45 ml/min. The temperature behavior of the coolant at various 
longitudinal positions was explored based on the surface average method. The coolant 
pathway length is twice as long as the catheter length (2.2 m) since the coolant side has a 
turnaround which carries the coolant from the catheter distal tip to the coolant exit (Fig.1). 
Unlike the blood flow, the coolant temperature increases from the catheter inlet to the exit 
since the coolant will gain heat from both the aorta blood and the blood analog circulating 
inside the central lumen. From the catheter inlet to the distal tip, the temperature of the 




exchanging the maximum heat with the blood aorta and the blood analog inside the central 
lumen. The temperature of the coolant at the distill tip was found to be different at location 
1 and 2 (Fig.39), which explains why the coolant temperature at 1.1m (Fig.40) is equal to 
21.08 C and the temperature at the second pathway is equal to 20.68. 
          At a distance of 0.85 m (Fig.41) the coolant temperature slightly decreases due to 
the change in boundary conditions. In fact, that position presents a distance of 0.25 m from 
the inlet of the catheter. That portion of the catheter is outside the aorta blood and exposed 
to environment conditions. Since the environment conditions are colder than the aorta 
blood, the coolant temperature will slightly decrease. 
 
 
              





























Figure 41.  Plot of the coolant temperature from the distal tip to the coolant exit. The 
coolant side has a slot at the distal tip of the catheter to allow it to turnaround.              
This makes the coolant pathway twice as long as the catheter.  
 
         3.2.3.  CoolGuide temperature control of hydrogel without FNI-Needle. 
          3.2.3.1 Material and methods. To explore the CoolGuide™ sheath delivery 
capabilities we (1) developed a mock Endoscopic Ultrasound system that mimics the 
hydrogel delivery under body temperature conditions (without the needle),(2) Developed 
thermal fluid models using a finite volume method to predict water and hydrogel 
delivered temperatures that we validated with experiments. 
         3.2.3.1.1 Experimental setup. Mock EUS system: An in vitro experimental set-up 
was built to control and record hydrogel temperatures along the injection pathway 
(Fig.42). A temperature controlled sheath called CoolGuide™ was inserted into the EUS 
working channel to the proximal end. The EUS working channel was made of 3/8” ID 





























temperature. Body temperature was maintained at 37.5°C ± 0.5° C conditions and created 
using a heated reservoir and 3/32” ID Tygon wrapped tubing around the last 65cm EUS 
working channel.  
         A syringe pump was used to inject through the central lumen of the CoolGuide™ 
sheath 1) Distilled water and 2) hydrogel (30% Pluronic F-127). Both fluids were injected 
at variable flow rates ranging from 1-5 ml/min. The cooling console was used to deliver 
chilled distilled water through the coolant lumens. 
 
 
Figure 42. Schematic of the test setup without the FNI-Needle. From left to right 1) a 
syringe pump for injecting hydrogel or water  through the CoolGuide™ sheath 2) A cooling 
console used provide coolant to the CoolGuide sheath 3) A heated reservoir used to 
simulate body temperature conditions and 4) An EUS working channel made of stainless 
steel tubing exposed partly to ambient conditions and partly to body temperature. 





         Seven Probes were used in the experimental work to measure the different fluids, 
ambient and body temperatures. One of the most challenging measurement was the fluid 
temperature exiting the sheath. Due to the CoolGuide sheath geometry (Fig.43), the top 
and bottom wall are surrounded by different temperatures which will lead to the non-
uniformity of the temperature inside the central lumen causing limitation of the exact exit 
temperature measurement. 
         The use of mixers at the exit would have helped the tested fluid to mix properly to 
allow for an accurate measurement. However, there are definitely challenges to 
implementing this technique. Given the low flow rates of the water and hydrogel 
circulating through the CoolGuide sheath, this may lead to elevation of the temperature 
exiting the sheath before reaching the probe causing inaccurate temperature measurement. 
         To investigate the effect of the probe orientation within the exit area, the probe was 
placed in three different locations inside the fitting: 1) close to the bottom wall, 2) close to 
the top wall (in contact with coolant lumens) and 3) on the centerline (Fig.44). For the three 
different cases the exit temperatures were collected for three data sets and with water as 
the flowing fluid since it is easier than hydrogel to deal with.  
          Fig.43 shows a SolidWorks sketch for the three different probe locations. The probe 
was inserted inside the fitting, and each time a picture of the fitting with the probe was 
imported into SolidWorks. The tip of the probe was then localized to determine its 




















Figure 44. SolidWorks 2D sketches showing the location of the probe for the three 
different cases: 1) centerline, 2) top wall and 3) bottom wall. A picture of the Y-fitting 
with the thermocouple location was imported into Solidworks, then a 2D sketch was 
drawn. 
 
e. Testing protocol 
A consistent testing method was maintained for both distilled water and hydrogel. The 
testing began when a set of initial conditions was met (Table 8). The test fluid was then 




 Table 8 
  Initial conditions for the testing setup 
Measurement Acceptable Value for Test Start 
Body temperature 37.5 C +/- 0.5°C 
Coolant to CoolGuide RTD 
Temperature 
< 5.0°C  
Coolant to CoolGuide Flow Rate > 35 ml/min  
Room Temperature 23.5°C +/- 3.0°C 
 
 
            3.2.3.1.2 Mathematical model. Our mathematical model was created to predict the 
fluid delivered temperatures when injected under body temperature conditions inside a 
mock endoscopic ultrasound and without the FNI-Needle. 
a. Geometry 
            Fig.45 shows a 3D model of the distal end of the mock EUS system including the 
CoolGuide™ sheath, the EUS and the fine needle injector (FNI). The CoolGuide™ is 1.5m 
long sheath and provides cooling to avoid hydrogel warming beyond its phase transition 
temperature or lower critical solution temperature (LCST) before its final destination inside 
the lesion. This study involves internal flow of 30% Pluronic F127 hydrogel inside the 






Figure 45. 3D model of the distal end of the mock EUS system showing the 
CoolGuide™ cooling sheath, the fine needle injection needle (FNI) and the air                     
gap between the mock EUS and the CoolGuide™. 
 
 
           For the purpose of modeling, we considered a triple lumen CoolGuide sheath 
positioned inside a mock EUS system and surrounded by non-moving air. The air gap was 
assumed to be a solid part given the thermal conductivity of air. This assumption is valid 
due to the non-motion of the air and will decrease computational time. The braided stainless 
steel mock EUS has an embedded layer of plastic (PVC). Fig.46 shows the mock EUS 












                
Figure 46. Schematic of the mock EUS system This figure shows a CoolGuide sheath 
(1), a Mock EUS (2), an embedded layer of plastic (PVC) (3) and an air region 
surrounding the CoolGuide sheath (4). The system is 1.53 m long including a 1.2m            
of mock EUS. The different layers in the 3D model derive from the existing device       




Dimensions of the CoolGuide™ sheath 
 
Geometry Dimension(cm) 
CoolGuide™  sheath Length 153.0 
EUS “Body Temperature” Warming Loop 65.0 
EUS length  125.0 
CoolGuide™  sheath Outer diameter  0.267 
CoolGuide™  sheath Inner diameter 0.157 




b. Governing Equations 
 
Similar to Model 1, the flow is assumed to be governed by the laminar Navier-Stokes 
equations, mass conservation, and energy conservation outlined in section (2.1.2). 
c.  Boundary and Initial Conditions 
                                                        
The model consists of different domains, the fluid domains for hydrogel, and distilled water 
flow, as well as the solid domains for the CoolGuide sheath, the air and the mock EUS. 
The thermal boundary condition between the solid and fluid is a conjugate heat transfer. 
The continuity is ensured at the fluid-solid interface, which means that the energy equations 
are coupled for the two domains to allow for heat transfer between them. 
Description of the boundary conditions is provided below (Fig.47 and Table.10): 
• 0.650 m of the mock EUS (Outer layer surrounding the CoolGuide™ will be held at a 
constant temperature equal to the temperature of the body (37.5°C). 
• All CoolGuide™ walls apply the no slip condition, which constrains the velocity to 
zero along it. 
• The hydrogel and water will be injected at variable mass flow rates and constant 
temperature inside the center lumen. 
• The coolant (distilled water) will be injected at constant mass flow rate and 
Temperature. 
• A pressure outlet was assigned to the hydrogel and coolant outlets 





 The natural convection heat transfer coefficient was determined based on the following 
equation:  
 
                                                                   Nu = 
h D
k
    ,                                                                 (3.26) 
where, h is the natural convection heat transfer coefficient ( W/m2-k),  k is the thermal 
conductivity of air (W/m-C), D is the CoolGuide diameter (m) and Nu, is the Nusselt 
number 
The natural convection heat transfer coefficient was determined based on Van Der Hegge 
Zijnen method [31] The Nusselt number is determined as a function of Grushof and Prandtl 
numbers as follows: 
                 Nu = 0.35+0.25( Gr Pr )
1
8 + 0.45 (Gr Pr )
1
4,                                               (3.27) 
where, the Grashof number is a dimensionless number which approximates the ratio 
of  buoyancy to viscous forces acting on a fluid. It is expressed using Eq. (3.28): 




 ,                                                             (3.28) 
where, g is the acceleration due to earth’s gravity.𝛽 is the coefficient of thermal expansion. 
Ts is the surface temperature (K) T0 is the bulk temperature (K). D is the cylinder diameter 





                                                       Pr=
Cp×μ
k
 ,                                                              (3.29) 
 
 
Figure 47. Schematic of the Mock EUS system with the boundary conditions. This 
includes hydrogel and coolant inlet temperatures and mass flow rates as well as the       

































d. Material Properties 
 
Two different fluids were tested and modeled: 1) distilled water and 2) 30 % Pluronic F127 
Hydrogel. Since there is a gap in knowledge about the Pluronic F127 hydrogel material 
properties, the thermal conductivity, specific heat and density of the hydrogel were 
assumed to be the same as water. Considerable uncertainty exists in those property values, 
so that the accuracy of the computed results may be affected to some extent by errors in 
those values. 
Boundary Boundary Condition Value 
Water/hydrogel  inlet [1]  Mass Flow Rate 1ml/min –6ml/min 
Water/hydrogel inlet 
temperature [1] 
Temperature 1ml/min –6ml/min 
Water/hydrogel exit 
[output] 
Pressure outlet 0 [Pa] 
Coolant inlet [2] Mass Flow Rate 40-45 ml/min 
Coolant inlet 
Temperature [2] 
Temperature 5-7 C 
Coolant exit [3] Pressure outlet 0 [Pa] 
Outer wall (Inside body) 
[4]  
Temperature 37.5°C 
outer wall (Outside 
body)[4] 
Temperature 30°C 
CoolGuide sheath outer 
wall  
Convection 6 W/m2-k 
Thermal exit boundary 
condition 




The dynamic viscosity of the hydrogel however was the only known property which is 
dependent on the temperature and the shear rate of the fluid. The material properties that 
were assigned to both fluids were a function of temperature. The solid domains however 
include, 1) the CoolGuide™ sheath which is made of Pebax with a thermal conductivity of 
0.29 W/m-C, 2) the Endoscopic Ultrasound made of stainless steel and, 3) the plastic part.    
 
Table 11 











Distilled Water 999.6     Variable 4186 Variable 
Hydrogel 1000      Variable 
 
4186 Variable 
Catheter(Pebax) 2160 - 1125 0.29 
EUS (Stainless 
Steel) 
2500 - 910 15.06 
Plastic(PVC)  1400 - 840 - 1170 0.19 





e. Modeling details  
 
All simulations were run on an ‘HPC cluster’ of high performance computing of Rowan 




of processors of 162.The cluster reduced our Computational time from 8 hours to 
approximately 2 hours compared to local computers. 
The governing equations were solved using the computational fluid dynamics software 
STAR-CCM+ based on the finite volume method. Convergence criteria included residuals 
of continuity, velocity, and energy as well as the average fluid exit temperature. The 
numerical computation was considered to be converged when the residual errors of all 
variables were less than 1×10-4. 
f. Solvers  
The segregated fluid temperature model was chosen. It solves the total energy equation 
with temperature as the solved variable. Enthalpy is then computed from temperature 
according to the equation of state. The Segregated solid energy was activated for the solid 
regions: The energy solver here controls the solution update for the segregated fluid 
energy model. Table 12 summarizes the modeling details used for the simulations.      
 
   Table 12 
   Modeling details with STAR-CCM+ 
Parameters Value 
Time stepping Steady-state state 
Tolerance 0.15 
Solver  Segregated flow/Segregated fluid 
temperature 






g. Mesh study 
A mesh independence study was performed by solving a steady flow simulation and 
predicting the water exit temperature for a variety of mesh sizes. The model was considered 
to be mesh independent when the average exit temperature over the entire domain did not 
significantly change with an increase in the number of mesh elements. 
For the conjugate heat transfer problem, we generated a polyhedral mesh and additional 
prism layers were activated on the fluid side of the fluid-solid interface. The solid part had 
no prism.  Fig. 48 shows the final mesh, approximately 19.8 million cells. Fig. 49 shows a 
close up section of the CoolGuide sheath mesh.  
 
 
Figure 48.  Final mesh for the mock EUS system including approximately 19.8                






            
Figure 49.  Final mesh generated for the CoolGuide™ model inside the EUS system.    
The volume mesh was generated using Polyhedral cells and 4 prism layers were         
added to the fluid-solid interface to resolve the boundary layer problem.  
 
 
h. Model Validation with water  
The delivery system was first validated with distilled water. Distilled water testing can be 
performed more rapidly, and without drastic changes in viscosity, compared to hydrogel. 
The aim of this work is to demonstrate the CoolGuide™ sheath ability to control distilled 
water temperatures for a range of flow rates. The flow rates were varied from 1ml/min to 
6 ml/min with 1ml increment. Through these tests we can gauge the system’s ability to 
maintain the temperature of the delivered fluid below body temperature and hydrogel 
transition temperature.  
The numerical model was validated with experimental data performed inside a mock EUS 
system. The water exit temperature was first collected using a probe placed at three 




location on the final results. Therefore, numerical solution was compared to present data 
collected with the appropriate probe location. 
i. Effect of the probe location on the water exit temperature  
Fig. 50 shows the water exit temperature for the three different probe locations. Three flow 
rates were tested: 2, 4, and 6ml/min. The centerline and bottom wall probes measured 
almost the same exit temperatures, however the top wall probe measured lower 
temperatures as expected due to its contact with the coolant lumens (Fig.44), where the 
temperature tend to be lower than the one measured at the centerline or the bottom wall. 
Since the centerline and bottom wall probes gave almost the same results, we decided to 
use the centerline probe. All experimental work therefore was done using the centerline 






Figure 50. Experimental data for the three different probe locations. The water flow      
rate varied from ml/min to 6ml/min. The error bars describes the standard deviation        
for three different data sets. 
 
j. Validation of the numerical solution with experimental results for the distilled water 
An accuracy check was conducted to validate the CoolGuide™ sheath model with water 
as the tested fluid. The inlet temperature was not constant for the different tests due to the 
low flow rates which cause the water temperature to warm up quickly from the injection 
location to the probe. These inlet temperatures were used as the inputs for our models.  
The results of the first set of experiments compared to numerical solution using water as 
the flowing fluid are shown in Fig.51. The temperatures were measured using the centerline 
probe. The numerical model predicted the delivered temperatures within an average of 0.5 
°C for all tested flow rates. The average error between numerical solution and experimental 







































Due to the low flow rates, no significant change was recorded in the water outlet 
temperature even though the flow rate was six times greater. Higher coolant flow rates 
provide colder temperatures and high heat transfer coefficients. Since the dominant thermal 
resistance is on the inside of the sheath, changing internal flow rates does not impact 
performance significantly. 
 
Figure 51. Water experimental data compared to numerical solution prediction              
with varying flow rates and given the same inputs. The error bars represent the         
sample standard deviation for three data sets.    
 
 
k. Cross sectional views of the distilled water temperature and dynamic viscosity at the 
exit of CoolGuide sheath 
Cross sectional views of the sheath model (Fig.52) show the temperature and dynamic 


































was injected at 2ml/min. The choice of this flow rate was arbitrary and aims to explore the 
behavior of the water around the CoolGuide™ sheath.  
 
 
               
Figure 52. Temperature and dynamic viscosity distribution of the water at the exit.         
The flow rate is 2ml/min. 
 
 
l. Water temperature along sheath 
Fig. 53 shows the water temperature profile as a function of the CoolGuide™ sheath length 
for a flow rate of 2 ml/min. These plots explore the water behavior inside the central lumen 
and at various longitudinal positions from the inlet to the exit (1.53m) with 0.2m increment. 





From the inlet of the sheath to the outlet, the water temperature increased from 4.85°C to 
11.44 °C steadily. Even though the temperature was increasing, the CoolGuide™ sheath 




Figure 53. Plot of the water temperature as a function of the CoolGuide™ sheath             
length for a 2 ml/min flow rate. The water enters at a constant temperature (5.85°C)         

































m. Model Validation with Hydrogel (30% Pluronic F127) 
 
m.i. Determination of the power law equation for 30% Pluronic F127 
Rheology models are grouped under the categories; (1) empirical, (2) theoretical, and (3) 
structural. Empirical models such as the power law model are deducted from experimental 
data.[24].  
The hydrogel viscosity is dependent on the temperature and shear rate. In order to gain 
further understanding on the behavior of the 30 % Pluronic F127 a rheological study was 
first conducted. The primary task of mathematical modeling applied rheology is to predict 
the rheological properties of 30% hydrogel F127.From the work of Abdel-Hamid et 
al(2006) the power law model was the best fit for pluronic compared to the Bingham and 
Casson model. 
m.ii. Rheometry 
Rheological measurements of pluronic F127 (30% by volume) were performed on a 
strain-controlled rheometer. An oscillating geometer (parallel plate, 20 mm diameter) 
with the Peltier thermal stage serving as the lower surface, was used to run flow sweeps 
on the F127 hydrogel. Fig. 54 shows the experimental setup. For each test 0.5 ml of test 
solution was in contact with the lower plate and the upper geometer was lowered to 
contact the solution. The temperature dependence of rheological properties was studied at 
a range of 4C to 30 C. The shear rate was varied at a constant temperature each time.  




for the 30% hydrogel at each temperature. The flow profiles were investigated by fitting 
the Power Law model to the rheological data. Fig.55 shows the variation of the viscosity 
as a function of the shear rate for different temperatures. The viscosity decreases with an 




Figure 54. Actual picture of the Rheometer setup used for the rheology analysis. An 







                To find the power law index (n) and the consistency factor (K), both sides of 
Eq.(2.12) were changed into the logarithmic of shear rate Eq.(3.30) to get a linear plot 
(Fig.56). The power law model describes the data of shear thinning fluid [32]. 
                                        Log (𝜇)= (n-1) log (γ˙) + log (k)                                                 (3.30) 
Table 13 summarizes the power law index (n) and the consistency index (k) for the two 
different temperatures. Those values were used in the 3D model. The viscosity was 
modeled using the power law model. 
.  
Figure 55. Viscosity versus shear rate plot at different temperatures. The temperature of 































30% Pluronic F127 at 8 C
30% Pluronic F127 at 12 C
30% Pluronic F127 at 14 C
30% Pluronic F127 at 20c





Figure 56.Logarithmic plot of the viscosity versus shear rate at different temperatures. 




Rheological properties of 30% Pluronic F127 
 
       
 
       From the distilled water model and testing, the ability of the CoolGuide™ sheath to 
control fluid temperatures while delivery under body temperature conditions was 
demonstrated. In this section, we intend to investigate the CoolGuide™ sheath ability to 




























30 % Pluronic F127 n k 
At 8 C 0.54 2.29 




m.iii. Validation of the numerical solution with experimental results 
             A comparison plot of the hydrogel exit temperature between present data and the 
numerical solution is shown in Fig.57. The coolant and hydrogel inlet temperatures were 
variable for each test, which explains the large offsets between the three tests. 
A good match exists between the numerical solution and the experimental work with an 
average error of 2% between the two approaches. The delivered temperatures were found 
to be below the LCST (14 °C).  
      
Figure 57.30% Pluronic F-127 hydrogel exit temperatures as a function of the flow                 
rates. Experimental data are compared to numerical solution given the same inputs.        


































m.iv. Plot of the hydrogel temperature and dynamic viscosity along the CoolGuide sheath 
length 
              Fig. 58 shows how the hydrogel temperature increases as a function of the 
CoolGuide sheath length for a flow rate of 2 ml/min. Like explained in the water case, the 




Figure 58.30% Pluronic F-127 hydrogel temperature distribution as a function of the 
CoolGuide sheath length for a flow rate of 2ml/min. The CoolGuide sheath was able          
to control the hydrogel temperature and maintain it below the LCST. The LCST of         
the 30% Pluronic. 





























m.v. Comparison between the CoolGuide sheath and a standard sheath in terms of 
delivery capabilities 
           Two sheath configurations were explored 1) A standard circular sheath and 2) The 
CoolGuide™ sheath. The aim of this study is to show that the temperature controlled 
sheath has the ability to deliver hydrogel under body temperature conditions and keep it 
in liquid form along the injection pathway. 
Given the same inputs as the CoolGuide™ sheath, modeling results of the standard 
sheath showed that hydrogel delivered temperature exceeded the LCST (14°C). For a 
flow rate of  2ml/min, hydrogel delivered temperature was about 27°C with an average 
viscosity of  3010 Pa-s. The pressure recorded with numerical solution to deliver 
hydrogel through the sheath exceeded the limit provided with the syringe pump.  Fig. 59 
shows the temperature and viscosity distributions of the hydrogel through the 







                                
                              
Figure 59. Temperature and viscosity distributions along the two different sheath 
configurations. The CoolGuide sheath delivered hydrogel at a temperature of              
9.53 C and 9.5 PSIG while the delivery temperature with the standard sheath                
was about 27C. 
 
 
3.2.4.CoolGuide temperature control with an FNI-Needle aspirator. 
           3.2.4.1 Material and methods. To explore the hydrogel delivery capabilities we (1) 
developed a mock Endoscopic Ultrasound system that mimics the hydrogel delivery 
under body temperature conditions using an FNI-Needle, and (2) developed thermal fluid 
models using a finite volume method to predict water and hydrogel delivered 




            3.2.4.1.1 Experimental setup. Mock EUS system. An in vitro experimental set-up 
was built to control and record hydrogel temperatures along the injection pathway 
(Fig.60). The temperature controlled sheath (CoolGuide™) was inserted into the EUS 
working channel to the proximal end to provide temperature control along the injection 
pathway. A needle was placed inside the whole assembly and was kept in contact with 
the CooGuide sheath. A 3 cm portion of the needle was sticking out of the mock EUS and 
the CoolGuide to mimic the injection procedure inside the body. 
         A syringe pump was used to inject through the central lumen of the CoolGuide™ 
sheath 1) Distilled water at variable flow rates and 2) hydrogel (30% by volume Pluronic 
F-127). The cooling console was used to deliver chilled distilled water through the coolant 
lumens. 
              
 
Figure 60. Schematic of the test setup without the FNI-Needle. The mock tissue was 






a. Mock tissue creation  
           A temperature controlled mock tissue was created to mimic body temperature 
environment to the 3 cm needle outside of the Mock EUS system. The tissue was created 
using a 3 cm Aluminum part, and drilled in the center to allow for the needle insertion 
(Fig.61). The hole was 0.049”, which is slightly bigger than the needle outer diameter. 
Any gap between the needle and the mock tissue was sealed using conductive paste 
(Halnziye HY710 20g Tube Syringe Silver Thermal Paste). The body temperature 
environment was created using a New Era heater (New Era Pump System Inc, USA) 
where the primary heating pad was wrapped around the Aluminum part (Fig. 62). 
 
                    
Figure 61. Top and side views of the mock tissue created using Aluminum part              







Figure 62. Primary heating pad and the heating pad connector. The primary red            
heating pad is wrapped around the Aluminum part and a temperature set point of               
37° C was adjusted to create the body temperature conditions around it. 
 
          3.2.4.1.2 Mathematical model. Our mathematical model was created to predict the 
fluid delivered temperatures when injected under body temperature conditions inside a 
mock endoscopic ultrasound and the FNI-Needle. 
a. Geometry 
Fig. 63 shows the geometry of the delivery system with the FNI-Needle. This geometry is 







Figure 63. Schematic of the mock EUS system This figure shows a CoolGuide        
sheath (1), a Mock EUS (2), an embedded layer of plastic (PVC) (3) and an air                   
region surrounding the CoolGuide sheath (4). The system is 1.53 m long including                
a 1.2m of mock EUS.  
 
           To accurately predict delivered temperature, two different needle positions were 
modeled, 1) fully eccentric, and 2) needle touching the coolant lumens (Fig.64). Modeling 





               
Figure 64. Needle orientations within the CoolGuide sheath. Two configurations              
were studied (a) needle touching the CoolGuide bottom wall and, (b) needle touching            
the coolant wall. The second configuration (b) was the closest to experimental set-up. 
               
Table 14  
Dimensions of the CoolGuide™ sheath 
Geometry Dimension(cm) 
CoolGuide™  sheath Length 153.0 
Needle length 65.0 
EUS “Body Temperature” Warming Loop 173.0 
EUS length  125.0 
CoolGuide™  sheath Outer diameter  0.267 
CoolGuide™  sheath Inner diameter 0.157 
Coolant lumen hydraulic diameter 0.0458 
 
 
b. Governing equations 
 
         Similarly, to Model 1 and 2, the flow is assumed to be governed by the laminar 





c. Boundary and initial conditions    
 
             The boundary conditions were fixed in a manner suitable to reproduce the 
experimental conditions.The model consists of two domains, the fluid domains for 
hydrogel, and distilled water flow, as well as the solid domains for the CoolGuide sheath, 
the air, the needle and the mock EUS. The thermal boundary condition between the solid 
and fluid is a conjugate heat transfer. The continuity was ensured at the fluid-solid and 
solid-solid interfaces. Description of the boundary conditions is provided below (Fig.65 
and Table.15): 
• 0.650 m of the mock EUS (Outer layer surrounding the CoolGuide™ will be held at a 
constant temperature equal to the temperature of the body (37.5°C). 
• All CoolGuide™ walls apply the no slip condition, which constrains the velocity to 
zero along it. 
• The hydrogel and water will be injected at variable mass flow rates and constant 
temperature inside the center lumen. 
• The coolant (distilled water) will be injected at constant mass flow rate and 
Temperature. 
• A pressure outlet was assigned to the hydrogel and coolant outlets 
• The CoolGuide sheath and the needle outside the EUS and the body were insulated. 






Figure 65.Schematic of the Mock EUS system with the boundary conditions.                
This includes hydrogel and coolant inlet temperatures and mass flow rates as well          













Table 15  
Boundary conditions imposed on the CoolGuide™ model 
Boundary Boundary Condition Value 
Water/hydrogel  inlet  Mass Flow Rate 1ml/min -5ml/min 
Water/hydrogel inlet 
temperature 
Temperature 1ml/min -5ml/min 
Water/hydrogel exit 
[output] 
Pressure outlet 0 [Pa] 
Coolant inlet  Mass Flow Rate 40-45 ml/min 
Coolant inlet 
Temperature  
Temperature 5-7 C 
Coolant exit  Pressure outlet 0 [Pa] 
Outer wall (Inside body)   Temperature 37.5°C 
outer wall (Outside body) Temperature 30°C 
Outer wall of the needle Insulated  0 W/m2 
CoolGuide sheath outer 
wall  
Insulated 0 W/m2 
Outer wall of the 3 cm 
needle ( outside of the 
EUS) 






d. Material properties 
 
              Two different fluids were tested and modeled: 1) distilled water and 2) Pluronic 
F-127 Hydrogel.  
The solid domains include, 1) the CoolGuide™ sheath which is made of Pebax with a 




3) the needle made of Nitinol and, 3) the plastic part made of PVC. Table 16 lists the 
different materials used in the models. 
 
Table 16 
Materials properties of the different fluids and solids used in the 3D model. 
 
e. Mesh study 
For the conjugate heat transfer problem, we generated a polyhedral mesh and additional 













999.6     Variable1 4186 Variable2 
Hydrogel 1000      Variable3 4186 Variable2 
Sheath 
(Pebax) 




7500 - 910 15.06 
Plastic(PVC)  1400 - 840 - 1170 0.19 
Air 1.225 - 1000 0.02633 
Needle 
(Nitinol) 
   18 
(1) Function found in appendix C 
(2) Function found in appendix D 




no prism layers .Fig.66 shows the final mesh generated (19.8 cells). Fig.67 shows a close 
up section of the Mock EUS system mesh.  
 
 
Figure 66. Final mesh for the mock EUS system including 52018295 cells. The               




Figure 67. A close-up section of the mesh generated for the mock EUS system.                 
The volume mesh was generated using Polyhedral cells and 4 prism layers were            




            3.2.4.2 Model validation. Validation without the mock tissue: The delivery 
system was first validated without the mock tissue. The 3cm needle out of the mock EUS 
was only exposed to ambient conditions for simplification.  
       The aim of this work is to demonstrate the CoolGuide™ sheath ability to control 
distilled water temperatures for a range of flow rates. The flow rates were varied from 
1ml/min to 5 ml/min with 1ml increment. Through these tests we can gauge the system’s 
ability to maintain the temperature of the delivered fluid below body temperature and 
hydrogel transition temperature.  
An accuracy check was performed to validate the mock EUS system with water as the 
tested fluid.  We chose water for simplicity reasons. Two needle orientations were modeled 
(Fig.64) to investigate the impact of its orientation on the delivered temperature. 
          Numerical models were validated with experiments. Fig. 68 shows the water 
delivered temperatures as a function of the flow rates. The temperature behavior showed 
that all model predictions for configuration (a) were within 2 % of experimental data. 
However configuration (b) was approximately 30 % off from the actual data. 
          Results showed that configuration ‘a’ is closer to experiments. This was expected 
because the needle was not fully eccentric inside the CoolGuide sheath but most of the time 





Figure 68. Water delivered temperature as function of the delivery length using FNI-
Needle. The numerical solution using the two different configurations was compared to 
experimental results. Configuration (b) delivered lower temperature compared to 
Configuration 
 
         There is a 5 C difference in the temperature prediction with the two different 
configurations. This is due to the orientation of the needle inside the CoolGuide sheath. 
For configuration (a), the needle is in contact with the bottom of the sheath which is 
touching the warm wall of the EUS (37 C). This causes the needle to be situated in the 
region of the air that is exposed to warmer temperatures. For configuration (b), the needle 























Numerical solution configuration (b)




depending on the needle location within the CoolGuide. Fig. 69 and 70 show how the 
cooling of the fluid circulating inside the needle differs for the two cases.  
 
        
Figure 69. Water temperature distribution at a cross section of the EUS system          
using the two different needle orientation inside the CoolGuide sheath (from left to          
right, Configuration “a” and “b”). The placement of the needle towards the coolant 
lumens (Configura 
 
    
Figure 70. Water temperature distribution at the exit showing the difference between         
the two needle locations inside the CoolGuide sheath. Placing the needle against the     





a. Validation with the mock tissue 
ai. Water delivered temperature  
           The Mock EUS system was validated with a mock tissue surrounding the needle. 
Configuration.2 of the needle was used in our modeling since it is the closest to the 
experimental results. Fig. 71 shows the delivered temperatures as a function of the water 
flow rate. Numerical solution was compared to experimental work and a reasonable match 
between the two approaches was noticed. Some errors could be attributed to experimental 
work limitations such as maintaining the mock tissue at body temperature. The standard 
deviation for the flow rates 2ml/min and 3ml/min were approximately twice the other 
standard deviations due to some experimental errors caused by the mock tissue temperature 
which was hard to maintain at body temperature condition. This leads the exit temperature 







Figure 71. Water exit temperature as a function of the flow rate. Results are a   
comparison between numerical solution and experimental work. Error bars presents       
the standard deviation between three data sets. 
 
a.ii. Water delivery pressure 
             Water delivery pressure was validated with experiments. Fig.72 shows a 
comparison plot between the numerical solution and the experimental work.  The average 
error between the numerical solution and experimental work was about 10.5%. Some 
differences in the predicted values could be attributed to some uncertainties about the 
actual inner diameter of the needle. There is a strong relationship between the diameter 
and the pressure drop and any difference could affect the final results.  For this reason, 
two different inner diameters were modeled. The ID of 0.92 mm gave more accurate 


































Figure 72. Pressure variation as a function of the water flow rate. The experimental      
data were compared to three numerical solutions: 1) EES model, 2) CCM+ prediction 
with an inner diameter of 0.88mm, and 3) CCM+ prediction with an inner diameter of 
0.92mm. 
 
a.iii. Temperature distribution along the injection pathway 
         As soon as the hydrogel exits the temperature controlled region (location 1) shown 
in Fig.73 and enters the 3cm needle it warms up and exits the needle at almost body 
temperature (Location 4). Fig. 74 shows the temperature distribution along the 3 cm needle 
out of the mock EUS system and at the four different locations (Fig.73). This region is 
heated with body temperature, and since the flow is very slow, the fluid delivered warms 
up quickly as soon as it exits the controlled region. The exit temperature at the exit of the 
mock EUS (location 1) is 13.1 C for a flow rate of 3ml/min, however it exits the needle at 



































    
Figure 73.  Schematic showing the four studied locations along the 3cm heated needle. 
 
 
    
                                  Location 1                                                 Location 2 
    
Location 3                                                  Location 4 
Figure 74. Water Temperature distribution along the 3cm portion of the needle. The 





           Modeling results showed that the CoolGuide sheath was able to control water 
temperature along the portion of the needle inside it. Fig.75 shows the temperature profile 
of the water along the 3cm needle. As soon as it exits the temperature controlled region the 
water temperature hits body temperature.  
 
Figure 75. Hydrogel temperature distribution along the 3 cm needle for the flow            
rates of 2 ml/min and 4ml/min .The hydrogel temperature rises until it reaches almost 
body temperature as soon as it leaves the temperature controlled region. 
 
a.iv. Validation with 30% Pluronic F127 hydrogel 
         Fig.76 shows the hydrogel exit temperatures as a function of the flow rates. As the 
flow rate increases, the exit temperature decreases but still higher than 30 C. The numerical 
model predicted the delivered temperatures within an average of 0.9 °C for all flow rates 



































3%. These differences are due to some measurement uncertainty related to the different 
probes used in the experimental setup especially the probe measuring the exit temperature. 
 
Figure 76. Hydrogel Delivered temperature as a function of the flow rate. This               
plot is a comparison between the numerical solution and experimental data. 
 
          Fig.77 shows the delivery pressure for the different flow rates. Experiments and 
modeling showed that the hydrogel is injectable under body temperature conditions with 






































Figure 77. 30% Pluronic hydrogel delivery pressure at different flow rates.                     
This shows a comparison plot between numerical solution and experiments. 
    
 Data and modeling results showed that thermosensitive hydrogel was injectable through 
the delivery system. Modeling and experiments showed that the hydrogel was leaving the 
tip of the needle at almost body temperature (gel form), however modeling results 
showed that the hydrogel at the exit of the temperature controlled zone was in liquid form 
at a temperature of 13.1 C. The hydrogel was heated quickly at the 3cm needle due to the 
low flow rates and the high conductivity of the needle. Without a temperature controlled 
sheath the hydrogel pumping through the needle would be impossible.  Fig.78 shows the 




































               
Figure 78. Hydrogel delivery temperatures and viscosity distribution without the 
temperature controlled sheath. The hydrogel delivery pressure required is unrealistic 

















Hydrogel Temperature Control Refinement 
                The objective of this chapter is to enhance the hydrogel delivery system 
capabilities. We aim to optimize the original CoolGuide™ sheath design to achieve better 
cooling by improving the temperature control and reducing the delivered temperatures. 
4.1.  Thermal Fluid Model Assessment  
                 In this study, thermal fluid models were developed, explored and compared to 
experimental data to investigate the CoolGuide™ sheath ability to control and deliver 
lower temperatures fluids for medical treatment. The study showed that the CoolGuide™ 
has the ability to, 1) control fluid temperatures as they were injected under body 
temperature conditions, and 2) reduce delivered temperatures.  
Even though the work established a confident framework for possible pancreatic cancer 
treatment, it has some limitations. The original CoolGuide™ catheter was designed for 
heart cooling application, thus it should be optimized to improve temperature control 
performances.. 
4.2.  Device Design Refinement 
               4.2.1 Refinement goals. The goal was to allow a boarder range of possible 
designs for the CoolGuide™ sheath to deliver hydrogel deeper inside the body. Features 




improve temperature control capabilities.  We seek to deliver thermosensitive hydrogels 
under the LCST and keep it liquid along the injection pathway. 
            In chapter 3, it has been demonstrated that the needle location within the 
CoolGuide™ strongly impacts the delivered temperatures. The closer the needle to the 
coolant walls, the cooler the exit temperature will be. Therefore we decided to explore 
CoolGuide™ designs that will allow the needle to be touching the coolant walls or 
completely surrounded by them. 
             4.2.2 Refinement protocol. The CoolGuide™ sheath was redesigned to allow for 
lower hydrogel delivered temperatures. Unfortunately the 3cm part of the needle could 
not be controlled because it has to stick inside the tumor to allow for the drug injection. 
           For refinement, features of the CoolGuide sheath will be modified to help improve 
temperature control along the injection pathway. To achieve that, we will change the 
coolant lumens geometry to allow for a better cooling. By modeling the new design of the 
sheath we will investigate the impact of the coolant lumens on the hydrogel delivery 
through the delivery system. A concentric design (Fig.78) was explored, here the coolant 
lumens are surrounding the central lumen from all sides to allow for better cooling. 
The inner lumen diameter was also optimized for the eccentric model to reduce the air gap 







            Fig. 79 shows the geometries of the two different designs used for optimization 
purpose. The two sheath designs were modeled separately inside the EUS system. Model 
A represents the concentric design, here the coolant lumens were refined. Model A is the 
same as the original model except that the central inner lumen was refined, the ID was 
reduced by 40 %. 
 
                       
           Model A                                                                 Model B 
Figure 79.Two different CoolGuide designs emphasizing the refined features.              
Model A shows the concentric design. Model B shows the optimized eccentric       
design. 






b. Governing equations 
           The same governing equations as model 3 were used in this model. This includes 
the Navier-Stokes equations (Eq. 2.1), the conservation of mass (Eq. 2.2) and the 
conservation of energy (Eq. 2.6). 
c. Boundary conditions  
          Boundary conditions from Model 3 were used for the optimized models (Table 15). 
d. Mesh  
          A mesh study was conducted on both optimized models (concentric and eccentric). 
The final mesh generated for both models was polyhedral mesh with prism layers. Model 
A includes the concentric sheath and has 27 million cells, model B includes the eccentric 
sheath and has 25 million cells. 
                 
Figure 80.Mesh generated for the two different models. Model A includes the          
concentric sheath and has 26925529 cells, model B includes the eccentric sheath          




e. Material properties  
         Same material properties as the original design were used for both optimized 
models (Table 16). 
4.3.  Optimization Outcomes 
           4.3.1 Temperature profile at the exit of the sheath. Fig. 81 shows the hydrogel 
exit temperatures at Location 1 (Fig.71). The plots are a comparison between the two 
optimized models and the original CoolGuide™ design. The two optimized models 
reduced the delivered temperature and improved the cooling capabilities. The optimized 
eccentric design reduced the average exit temperature by 54 % while the concentric 
design reduced the exit temperature by 37 %.  This difference in performance is due to 
the difference in the two geometries. The concentric design allows for a larger area of the 





Figure 81. Comparison plot between the three different sheath designs in terms of needle 
temperature at the exit of the sheath. 
 
a. Temperature distribution along the 3 cm needle (Comparison between original 
design and the optimized eccentric 
           Fig.82 shows the temperature variation along the 3 cm needle for the two different 
design configurations. Although the hydrogel exits at the same temperature with the two 
different designs, the Eccentric optimized model showed its ability to deliver lower 




































Figure 82. Hydrogel temperature distribution along the 3cm needle length for a     
hydrogel flow rate of 2 ml/min. The plot is a comparison between the original         
design and the optimized eccentric design. 
 
 
          4.3.2 Delivery pressure.   Fig. 83 shows the delivery pressure comparison plot 
between the two optimized models and the original CoolGuide™ design. The two 
optimized models reduced the delivery pressure. The optimized eccentric design reduced 
the average delivery pressure by 60 % while the concentric design reduced the average 





































Figure 83.Pressure drop variation with hydrogel flow rates. The plot is a comparison 
between three different sheath configurations.  Design optimization lowered delivery 
pressure. 
 
a. Temperature distribution at the exit 
          To explore the different designs cooling capabilities, cross sectional plots of the 
temperature distribution at the exit location were displayed. Fig.84 shows the temperature 
distribution at the exit along the CoolGuide, needle, hydrogel and air regions for the three 
different designs. This figure aims to emphasize the heat transfer process between the 
coolant lumens and the hydrogel inside the central lumen. Model B reduced the average 










































                               Original design                Model B – Optimized Eccentric 
 
Model C – Optimized Concentric 
Figure 84. Hydrogel temperature distribution along a cross sectional area at the sheath 
exit showing the three different sheath designs. The optimized models have shown a 












Conclusion and Future Work 
          This chapter provides a summary of the work conducted in this thesis and the 
challenges faced. We will also discuss the limitations of the models and suggest 
recommendation for future work for improvement. 
5.1. Re-Statements 
         In this work, the hydrogel delivery under body temperature conditions was 
challenging due to its thermosensitive properties that leads to a sharp increase in viscosity. 
A temperature controlled sheath was used along the injection pathway to help keep the 
hydrogel below its phase transition temperature (LCST). 
         We developed thermal fluid models to investigate the cooling performances of the 
temperature controlled sheath that helps deliver thermosensitve hydrogels using an EUS 
system and an FNI-Needle under body temperature conditions. All models were validated 
with in-vitro testings. 
          The first model used a finite volume method to investigate the cooling performances 
of a CoolGuide catheter to deliver blood analog at lower temperatures than body 
temperature to save heart tissue. This model was validated with experiments inside a mock 
cardiovascular system. Blood analog was the working fluid with a temperature dependent 
viscosity. The study showed that the catheter delivered temperatures within 1°C for high 




are some errors between the different results, the cooling capacity of 20 W was exceeded 
for a flow rate greater than 25ml/min which is in good agreement with published data. The 
exit temperatures and cooling capacity are dependent on the blood analog mass flow rate.  
             In the second model, a modified version of the CoolGuide catheter now called 
CoolGuide sheath was used with an EUS system without an FNI-Needle to help deliver 
thermosensitive hydrogels under body temperature conditions. For validation, two fluids 
were used 1) water and, 2) Pluronic F127 hydrogel (30% by volume). Distilled water was 
first injected into the system to show the ability of the CoolGuide sheath to control the 
tested fluid temperatures. The water was modeled as a Newtonian fluid with a temperature 
dependent viscosity. However, the hydrogel was modeled as a shear and temperature 
dependent fluid using the Power-Law-WLF model with consideration of a temperature 
shift factor. This equation correlates the hydrogel viscosity to the shear and temperature 
dependency. The flow rates were varied from 1ml/min to 5 ml/min with 1ml increment.  
Results showed that the CoolGuide sheath has the ability to control fluid temperature and 
deliver the fluid below its LCST. 
            The third model, was validated using the same in vitro set-up as the second model 
with the addition of an FNI-Needle. The FNI-Needle was placed inside the CoolGuide 
sheath and hydrogel was injected through it.  
          The numerical model predicted the delivered temperatures within an average of 0.9 
°C for all flow rates tested. The average error between numerical solution and experimental 




          In model 4, we provided possible CoolGuide sheath design refinements to improve 
delivery outcomes. Two different sheath designs were explored. Both designs showed their 
ability to reduce delivered temperatures for the different flow rates compared to the actual 
design and improve temperature control. 
5.2. Limitations of the Work 
           Each of the models described in this thesis have some limitations. Model 1, 
utilized the blood analog as a Newtonian fluid with a temperature dependent viscosity. 
           For model 2 and 3, an obvious limitation was related to the hydrogel thermal fluid 
properties: density, thermal conductivity, specific heat, and dynamic viscosity. In this study 
the hydrogel viscosity was modeled using the power law model with the temperature shift 
factor. The coefficients C1 and C2 were assumed to be constant and derived from the 
literature. The other properties of the hydrogel were assumed to be equal to water.  
           Another limitation was related to the fidelity to estimate fluid exit temperature 
because there is a potential for large offsets between actual exit temperature and that 
reported by a probe located in the exit as described in Chapter 3. The use of mixers at the 
exit would have helped the tested fluid to mix properly to allow for an accurate 
measurement. However, there are definitely challenges to implementing this technique. 
Given the flow rates of the water and hydrogel passing through the CoolGuide sheath, this 
may lead to elevation of the temperature exiting the sheath before reaching the probe 





5.3.  Future Work 
           This work demonstrated the efficacy, feasibility, and safety of using a temperature 
controlled device to successfully deliver hydrogels.  
Future work will include the use of a real endoscope in the experimental to 
accurately mimic the real EUS application. The approach of exit temperature measurement 
should be improved for more accurate results. The thermal fluid model should take into 
consideration that the coefficients C1 and C2 of the temperature shift factor are determined 
based on a rheology study of the Pluronic F-127. The exact values based on experimental 
work will improve modeling outcomes. 
            Model 4, was only a CFD prediction. Even though these models showed the ability 
of the refined CoolGuide™ designs to reduce hydrogel delivered temperatures for a range 
of flow rates, experimental work is needed to validate these models and build confidence 
for future applications. 
            Another issue that needs to be addressed is the temperature surrounding the 3 cm 
needle. Insulation could be provided at that portion of the needle to prevent hydrogel 
transitioning. The Insulon® device (Fig. 83) could present a thermal barrier to limit the 
heat exchange at the 3cm needle, which will help achieve lower delivered temperatures. 
This device works fine even for components surrounded by extremely high or low 






Figure 85.Insulative ideas for the 3 cm needle to prevent hydrogel transitioning [33]. 
Thethermal barrier helps prevent heat exchange with the body temperature environment. 
 
 
          Other hydrogel types and concentrations could be explored in future studies.  In fact, 
Pluronic F127 has been shown to have poor mechanical stabilities and cannot sustain drug 
release over a long period of time at body temperature.  This work sets the stage for the 
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 Equation of the Viscosity as a Function of Temperature for the Glycerol Mixture 
(38% by volume) 
 
                                 μ (T)=10.31exp(-0.035T)                                                             (31) 
 

















Maxwell Derivation for Thermal Conductivity Composite [35] 
 













keff effective thermal conductivity (W/m.K)  
k1 thermal conductivity of embedded material (W/m.K)  
k0 thermal conductivity of continuous phase(W/m.K)  














  Table 17 
  Water viscosity as a function of temperature 
 




















Figure 86. Thermal properties of water [36] 
 
 
 
 
 
 
 
